Abstract:Understanding mechanisms of ageing remains a complex challenge for biogerontologists, but recent adaptations of evolutionary ageing theories offer a compelling lens in which to view both age-related molecular and physiological deterioration. Ageing is commonly associated with progressive declines in biochemical and molecular processes resulting from damage accumulation, yet the role of continued developmental gene activation is less appreciated. Natural selection pressures are at their highest in youthful periods to modify gene expression towards maximising reproductive capacity. After sexual maturation, selective pressure diminishes, subjecting individuals to maladaptive pleiotropic gene functions that were once beneficial for developmental growth but become pathogenic later in life. Due to this selective 'shadowing' in ageing, mechanisms to counter such hyper/hypofunctional genes are unlikely to evolve. Interventions aimed at targeting gene hyper/hypofunction during ageing might, therefore, represent an attractive therapeutic strategy. The nematode Caenorhabditis elegans offers a strong model for post-reproductive mechanistic and therapeutic investigations, yet studies examining the mechanisms of, and countermeasures against, ageing decline largely intervene from larval stages onwards. Importantly, however, lifespan extending conditions frequently impair early-life fitness and fail to correspondingly increase healthspan. Here, we consolidate multiple evolutionary theories of ageing and discuss data supporting hyper/hypofunctional changes at a global molecular and functional level in C. elegans, and how classical lifespan-extension mutations alter these dynamics. The relevance of such mutant models for exploring mechanisms of ageing are discussed, highlighting that post-reproductive gene optimisation represents a more translatable approach for C. elegans research that is not constrained by evolutionary trade-offs. Where some genetic mutations in C. elegans that promote late-life health map accordingly with healthy ageing in humans, other widely used genetic mutations that extend worm lifespan are associated with life-limiting pathologies in people. Lifespan has also become the gold standard for quantifying 'ageing', but we argue that gerospan compression (i.e., 'healthier' ageing) is an appropriate goal for anti-ageing research, the mechanisms of which appear distinct from those regulating lifespan alone. There is, therefore, an evident need to re-evaluate experimental approaches to study the role of hyper/hypofunctional genes in ageing in C. elegans.

Ageing induces tissue-specific transcriptomic changes in <i>Caenorhabditis elegans</i>

Tissue-specific profiling of age-dependent miRNAomic changes in Caenorhabditis elegans

Age‐dependent changes and biomarkers of aging in Caenorhabditis elegans

Single-worm Quantitative Proteomics Reveals Aging Heterogeneity in Isogenic Caenorhabditis Elegans

Uncovering the Mechanisms of Caenorhabditis Elegans Ageing from Global Quantification of the Underlying Landscape

Quantitative transcriptional analysis of aging C. elegans

Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay

Ageing hallmarks exhibit organ-specific temporal signatures

Systematic transcriptome analysis associated with physiological and chronological aging in Caenorhabditis elegans

Full-length direct RNA sequencing reveals extensive remodeling of RNA expression, processing and modification in aging Caenorhabditis elegans

Considering Caenorhabditis elegans Aging on a Temporal and Tissue Scale: The Case of Insulin/IGF-1 Signaling

Caenorhabditis elegans as a Useful Model for Studying Aging Mutations

Consolidating multiple evolutionary theories of ageing suggests a need for new approaches to study genetic contributions to ageing decline

Ageing-associated changes in transcriptional elongation influence longevity

Transcriptome analysis of adult Caenorhabditis elegans cells reveals tissue-specific gene and isoform expression

A universal transcriptomic signature of age reveals the temporal scaling of Caenorhabditis elegans aging trajectories

Two conserved epigenetic regulators prevent healthy ageing

Caenorhabditis elegans in Chinese medicinal studies: making the case for aging and neurodegeneration.

Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans

Molecular mechanisms of dietary restriction in aging—insights from Caenorhabditis elegans research

Lack of T04C9.1, the Homologue of Mammalian APPL2, Leads to Premature Ageing and Shortens Lifespan in Caenorhabditis elegans